---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-016948"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-22T23:51:02.915979+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Opus Genetics stockholders elect nine directors and approve all proposals at 2025 annual meeting

## Summary
- All nine director nominees elected with >21M votes for each; no withhold votes exceeded 3.1M.
- Ratification of Ernst & Young as auditor for FY2025 passed with 30.2M votes for (94% of votes cast).
- Advisory say-on-pay proposal approved with 20.4M votes for (86% of votes cast).
- Conversion of Series A Preferred Stock into common stock approved with 16.7M votes for (84% of votes cast).
- Adjournment proposal passed but deemed moot as Conversion proposal already passed.

## SEC filing metadata
- accession: 0001140361-25-016948
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036125016948/0001140361-25-016948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036125016948/ef20048353_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-016948
- JSON: https://secwatch.observer/filing/0001140361-25-016948.json
- Plain text: https://secwatch.observer/filing/0001140361-25-016948.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.